Vitamin Shoppe (NYSE:VSI) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Sunday.

Other equities research analysts have also issued reports about the stock. Barclays decreased their target price on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Morgan Stanley decreased their target price on shares of Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Finally, Zacks Investment Research upgraded shares of Vitamin Shoppe from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. Four research analysts have rated the stock with a sell rating and five have given a hold rating to the stock. Vitamin Shoppe currently has a consensus rating of “Hold” and an average target price of $5.00.

Vitamin Shoppe (NYSE VSI) traded up $0.05 during trading hours on Friday, reaching $4.40. 616,046 shares of the company were exchanged, compared to its average volume of 507,543. Vitamin Shoppe has a 1 year low of $2.95 and a 1 year high of $24.85. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59. The stock has a market cap of $105.50, a price-to-earnings ratio of -0.42 and a beta of 0.69.

Vitamin Shoppe (NYSE:VSI) last issued its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.20). The company had revenue of $288.20 million for the quarter, compared to analysts’ expectations of $297.61 million. Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. Vitamin Shoppe’s revenue for the quarter was down 8.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.50 earnings per share. equities research analysts anticipate that Vitamin Shoppe will post 0.34 earnings per share for the current year.

Several large investors have recently added to or reduced their stakes in VSI. Eagle Asset Management raised its stake in shares of Vitamin Shoppe by 80.6% during the 3rd quarter. Eagle Asset Management now owns 5,855,854 shares of the specialty retailer’s stock worth $191,134,000 after buying an additional 2,612,583 shares during the last quarter. California State Teachers Retirement System raised its stake in shares of Vitamin Shoppe by 1.6% during the 4th quarter. California State Teachers Retirement System now owns 55,107 shares of the specialty retailer’s stock worth $1,802,000 after buying an additional 885 shares during the last quarter. Tocqueville Asset Management L.P. raised its stake in shares of Vitamin Shoppe by 28.6% during the 4th quarter. Tocqueville Asset Management L.P. now owns 42,946 shares of the specialty retailer’s stock worth $1,404,000 after buying an additional 9,547 shares during the last quarter. Leonard Capital Management Inc acquired a new position in shares of Vitamin Shoppe during the 4th quarter worth $3,434,000. Finally, Rhumbline Advisers raised its stake in shares of Vitamin Shoppe by 4.3% during the 4th quarter. Rhumbline Advisers now owns 45,118 shares of the specialty retailer’s stock worth $1,475,000 after buying an additional 1,855 shares during the last quarter. 90.35% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2017/12/31/valuengine-downgrades-vitamin-shoppe-vsi-to-hold.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.